Aldreya’s RASP Inhibitor ADX-629 enters phase 2 trial for COVID-19, asthma and psoriasis

Pharmaceutical firm AstraZeneca announced a new collaboration with Regeneron, an American biotechnology company headquartered in New York, focusing on researching, developing and commercialising small-molecule medicines for the treatment of obesity.

Ahmedabad-based pharmaceutical company Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market its Fulvestrant Injection, which is used in the treatment of breast cancer.

All India Institute of Ayurveda (under Ministry of Ayush) and UK’s London School of Hygiene and Tropical Medicine has signed an M.O.U to conduct a study on Ashwagandha for promoting recovery from Covid-19.

Japan-based pharmaceutical company Takeda has joined hands with Frazier Healthcare to launch HilleVax, Inc a biopharmaceutical company to develop and commercialise Takeda’s norovirus vaccine candidate.

The number of lung cancer incidences are on the rise among women, said lung cancer experts at Neuberg Centre for Genomic Medicine Panel discussion on ‘Lung Cancer Detection – How Late, is Late?’.

In a new study, researchers at the University of Illinois at Urbana-Champaign explored the use of microplasma — a highly focused stream of chemically excited ions and molecules —  for attacking the bacterial biofilms that resist antibiotic treatment in the middle ear. Their findings were published  in the journal npj Biofilms and Microbiome

The U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in adults with Type 2 diabetes mellitus.

A study based in Taiwan found that administering telmisartan, a medication used to treat high blood pressure, heart failure, and diabetic kidney disease reduces the risk of dementia and ischemic stroke in hypertensive (HT) patients with type 2 diabetes mellitus (T2DM).

The U.S. Food and Drug Administration (USFDA) has approved the immunotherapy drug pembrolizumab (Keytruda) as a treatment for patients with high-risk early-stage triple-negative breast cancer (TNBC) in combination with chemotherapy, announced the pharmaceutical company Merck & Co Inc.

A study conducted by researchers in Egypt has found that multiple myeloma patients mount variable and sometimes suboptimal responses after receiving the Pfizer-BioNTech or Moderna COVID-19 vaccines.

Signs of nerve damage in the cells of the surface of the eyes can help identify patients likely to suffer from ‘long Covid’, according to a new study conducted by researchers from Turkey and Qatar. The study was  published in the British Journal of Ophthalmology.

India reported 44,671 new COVID-19 incidences on Thursday. With as many as 549 fatalities recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,23,244.

The course of severe COVID-19 may be determined by the body’s antiviral response to initial infection, according to a study conducted by researchers from Massachusetts Institute of Technology (MIT) and Harvard University in the US.

Biocon Biologics has joined hands with the U.S. based Adagio Therapeutics to manufacture and commercialise an antibody treatment based on ADG20 for India and select emerging markets.

Scientists at Sanford Burnham Prebys have found how levels of a protein could be used in the future as a blood-based diagnostic aid for schizophrenia. The research also provides guidance for future analyses into the molecular basis of this serious, disabling mental disorder.

India has recently delivered 300 oxygen concentrators and 100 metric tons of liquid medical oxygen to Indonesia to help the country fight rising cases of coronavirus infection. At the same time, Indian Railways delivered 200 metric tonnes of liquid medical oxygen (LMO) to Bangladesh in 10 containers via the Oxygen Express.

Moolchand Hospital, Delhi has recorded a rise in neurological issues, including emergency cases of brain haemorrhage, among post-COVID-19 patients, it said in a statement.

A recent study conducted by the Indian Council of Medical Research and National Institute for Research in Reproductive Health (ICMR-NIRRH) has shown that embryos can get infected with Covid-19 in the womb from infected mothers and also during IVF procedures in laboratories which increases the chances of a miscarriage or even failure to conceive in both natural and IVF-induced pregnancy.

India reported 30,811 new COVID-19 incidences on Sunday. With as many as 418 fatalities recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,21,414.

Apollo Speciality Hospitals, Vanagaram has launched a new advanced quaternary care, level four epilepsy care center to help people living with epilepsy.

Sir Ganga Ram Hospital, in Rajendra Nagar, Delhi has recently reported 14 cases of large and multiple liver abscesses among patients who have recovered from Covid-19.

Nashik Civil hospital has started using a monoclonal antibody cocktail — Regn-Cov — to treat mildly symptomatic, but high-risk, Covid patients as the hospital received 100 vials from the state government.

A new clinical trial has shown that dolutegravir and ritonavir-boosted darunavir are equally effective second-line treatments for HIV-1, even for patients with resistance to nucleoside reverse-transcriptase inhibitors (NRTIs) in the regimen.

Men with moderate Covid infections had a decrease in overall sperm quality including sperm concentration and motility compared to men without infection, which persisted even up to 60 days post-infection, revealed a study conducted by the in-vitro fertilisation center, Crysta IVF.

India reported 40,286 new COVID-19 incidences on Friday. With as many as 541 fatalities recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,20,585.

The mental health organisation, Mpower – The Centre, in Kolkata has come forward to offer support to those in grief and bereavement during Covid-19.

Apollo Cancer Centre has recently performed a cyber knife radiosurgery procedure on a 34-year-old patient from New Zealand relieving him from symptoms of a special form of epilepsy called medial temporal lobe epilepsy (MTLE) while preserving his memories.  

A study by doctors at the Kokilaben Dhirubhai Ambani Hospital showed that the majority of Covid-19 patients, even those with severe Covid-19-related pneumonia, are likely to show signs of improvement in the lungs, both structurally and functionally within three months.

Findings of the Indian Council of Medical Research’s (ICMR) 4th national Covid serosurvey showed that a third of the population did not have SARS-CoV-2 antibodies, which means about 400 million people are still vulnerable to COVID-19 infection.
 

New research from Harvard Medical School’s Joslin Diabetes Center showed that the elevated levels of three specific circulating proteins are associated with protection against kidney failure in diabetes.

India reported 41,683 new COVID-19 incidences on Tuesday. With as many as 510 fatalities recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,19,021.

The US Food and Drug Administration (FDA) has approved the use of the transplant drug tacrolimus (Prograf) for the prevention of organ rejection in adult and pediatric patients receiving lung transplants.

India’s excess deaths during the pandemic could be a staggering 10 times the official COVID-19 toll, likely making it modern India’s worst human tragedy, according to a recent research.

Covid-19 may cause new onset of endocrine dysfunction: Study

A study conducted at a hospital in Dhaka, Bangladesh, has found high levels of antibiotic-resistant bacterial infections in children under 5 years with pneumonia in Bangladesh.

French pharmaceutical company Sanofi has sought permission to market its dengue vaccine in India. The French company placed its proposal seeking marketing authorisation, along with safety and immunogenicity data from phase 2 clinical trials in the country, before the Narendra Modi government’s expert panel.

The first of the 123 oxygen generation plants in Bihar was installed at the Indira Gandhi Institute of Medical Sciences (IGIMS), an autonomous medical institution of the government of Bihar, in Patna.

The World Health Organization’s (WHO) Odyssey Trial, a multi-country randomised trial sponsored by Penta, demonstrated the superior treatment efficacy for Dolutegravir (DTG) for Children with AIDS.

A research team at the Indian Institute of Technology-Hyderabad (IITH) led by Prof Shiv Govind Singh of the department of electrical engineering have developed an artificial intelligence-powered affordable COVID-19 test, named COVIHOME, that can be self-performed at home.

India reported 42,128 new COVID-19 incidences on Tuesday. With as many as 3,998 fatalities recorded on the day, the overall number of deaths reported in the country due to the pandemic escalated to 4,18,511.

A recent study published in the open-access journal PLOS ONE  has found that using a smartphone picture of a person’s inside the lower eyelid to predict anaemia is about 72% accurate.

Only 5.6% of the population are fully vaccinated of the 1.4 billion people in India, according to the India Covid-19 Situation Report  published by the International Medical Corps, a global humanitarian aid organisation.

India reported 38,109 new COVID-19 incidences on Friday. With as many as 560 fatalities recorded on the day, the overall number of deaths from the pandemic has escalated to 4,13,123.

Combining BRAF oncogene inhibitors and chemotherapy may be a very effective strategy for fighting metastatic melanoma, finds a new study published in the journal Oncogene.

The covid pandemic is now in the “early stages” of the third wave, warned World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus, looking at a global surge in cases of the Delta variant of the SARS-CoV-2 coronavirus.

Researchers at Karolinska Institutet in Sweden and other research institutions have, with the help of AI, identified a new and very promising biomarker for bacterial soft tissue infections.

Researchers at the University of California, United States, have successfully tested an experimental brain implant that translates brain signals into words on a computer screen.

In new research, which appeared in the Journal of Nutrition, the researchers demonstrated an association between consuming more whole grains and improved measures of risk factors for CVD.

India reported 39,071 new COVID-19 incidences on Thursday. With as many as 544 fatalities recorded on the day, the overall number of deaths from the pandemic has escalated to 4,12,563.

New treatment using 3D printed implants that could bring relief to numerous knee osteoarthritis sufferers has received approval to be trialled in UK patients, following a virtual “in-silico” trial that demonstrated its safety.

Insufficient exposure to UVB light from the sun may be associated with an enhanced risk of colorectal cancer, particularly in older age groups, reveals a new study from the University of California San Diego, USA.

India recorded 41,755 new COVID-19 incidences on Wednesday. With as many as 578 fatalities reported on the day, the overall number of deaths from the pandemic has escalated to 4,12,019.

Researchers from Harvard have recently reported results from a phase 3 clinical trial showing that among men with prostate cancer who received the experimental treatment- lutetium-177-PSMA-617 or LuPSMA, there was nearly a 40% reduction in deaths compared to those who did not.

BYL Nair Hospital in Mumbai Central has become the first civic-run hospital to start the phase 3 clinical trial of Zydus Cadila’s ZyCoV-D vaccine in children, in the city.

The China-based pharmaceutical company Sinovac Biotech’s CoronaVac vaccine was found to offer 83.5% protection against symptomatic COVID-19, according to the interim phase 3 trial results from Turkey.

A new study from the World Health Organization’s (WHO) International Agency for Research on Cancer (IARC), published in the journal Lancet Oncology, has found an association between alcohol and a substantially higher risk of several forms of cancer, including breast, colon, and oral cancers.

An anti-viral nasal spray, branded as Enovid that was developed by a research-based Canadian pharmaceutical company SaNOtize Research and Development Corp., and recently tested in the UK, can reportedly reduce the viral loads in confirmed COVID-19 cases by 95% in 24 hours and 99% in 72 hours.

The combination of the anti-PD-1 molecule pembrolizumab and low-dose ipilimumab (CTLA-4 blockade) showed significant antitumour activity among patients with advanced melanoma who previously failed prior immunotherapy, reveals a new study in Journal of Cinical Oncology.

A team of researchers led by Université de Montréal professor Jean-François Côté at the Montreal Clinical Research Institute, Canada, identified a protein called AXL whose action is crucial for hypoxia to take place in solid tumours.

Researchers from York University in Canada investigated how dancing to music affects various symptoms of Parkinson’s disease (PD).

A new study conducted by the Indian Council of Medical Research-National Institute of Epidemiology (ICMR-NIE), based on vaccination, hospitalisation data from Tamil Nadu police, has reaffirmed the effectiveness of COVID-19 vaccines in preventing death.

Abbott has launched Panbio COVID-19 rapid antigen self-test in India, for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms.

The Apollo Hospitals Foundation has decided to provide free medical support to under-privileged children through Saving A Child’s Health Initiative (SACHi) – a voluntary child organisation.

The World Health Organization (WHO) updated its guidance on initial reports of mild myocarditis following COVID-19 mRNA vaccines, saying that the side effects are often mild and respond well to conservative treatment.

Results of a new study presented at the European Society for Medical Oncology World Congress on Gastrointestinal Cancer 2021, indicated that people, especially those under the age of 50 years, may be at an increased risk of colon cancer due to the use of antibiotics.

AIMS hospital in Dombivli has begun administering the Russian Sputnik V Covid-19 vaccine. The vaccine is priced at Rs 1,150 per dose.

India reported 37,645 new COVID-19 incidences on Sunday. With as many as 720 fatalities recorded on the day, the overall number of deaths from the pandemic has escalated to 3,92,014.

New Delhi -based Mankind Pharma has received the license from the Defence Research and Development Organisation (DRDO) to manufacture and market its oral Covid-19 drug 2-deoxy-D-glucose (2-DG), the company said in a statement.

Recent research showed that two commonly used drugs for seasonal allergic rhinitis (SAR) and asthma – fexofenadine and montelukast- can be repurposed for the fight against Covid-19.

India reported 41,482 fresh COVID-19 incidences and 898 deaths on Saturday. The country has recorded 3,08,36,250 SARS CoV2 infections so far.

Significant amounts of atherosclerotic plaque have been found in the coronary arteries of people with HIV, even in those considered to be at low-to-moderate risk of future heart disease based on traditional measures, shows a study published in JAMA Network Open.

India reported 42,660 fresh COVID-19 incidences and 1,207 deaths on Friday. The country has recorded 3,07,94,768 SARS CoV2 infections so far.

Kerala is now put on alert following the outbreak of the Zika virus in the state. The number of cases due to the mosquito-transmitted disease went up to 14 on Friday following confirmation of 13 additional samples by the National Institute of Virology.

Tiruchi Mahatma Gandhi Memorial Government Hospital has recently installed a new 350-litre Pressure Swing Adsorption (PSA) oxygen plant.

A new study from Pfizer and BioNTech shows that a booster shot of their COVID-19 vaccine strongly extends protection and increases the human antibody response against the coronavirus.

Addressing a press conference after the first meeting of the Union Cabinet following its reshuffle on Wednesday, the Union Cabinet Thursday approved a Rs 23,123-crore package for improving health infrastructure to fight COVID-19.

Hetero has approached the Drugs Controller General of India for emergency use authorisation for investigational new drug Molnupiravir after a Phase-III clinical trial conducted by the company showed it led to fewer hospital admissions and quicker recovery for mild Covid-19 patients.

India reported 43,504 fresh COVID-19 incidences and 908 deaths on Thursday.

Providing community-based mental health care that is both respectful of human rights and focused on recovery is proving successful and cost-effective, according to new guidance released by World Health Organization.

With the tenure of the final year Doctor of Medicine (MD), Master of Surgery (MS) and Diploma courses extended for an unspecified period following the second wave of COVID-19 in the country, resident doctors have urged the government to consider the extended period as senior residency.

Delhi’s first genome sequencing laboratory was inaugurated at Lok Nayak Hospital on 7th July and will begin by sequencing 6-8 samples a week, according to hospital authorities.

Arthritis drugs tocilizumab and sarilumab reduced the risk of death and the need for ventilators among hospitalised Covid-19 patients, finds a new study which appeared in the Journal of the American Medical Association (JAMA).

India reported 45,724 fresh COVID-19 incidences and 819 deaths on Wednesday. The country has recorded 3,07,08,627 SARS CoV2 infections so far.

Mansukh Mandaviya, the current union minister for ports, shipping and waterways, will be in charge of the Health Ministry & Ministry of Chemicals and Fertilizers in the reshuffled union cabinet.

Psychedelic drug psilocybin may help increase the density of dendritic spines, small protrusions found on nerve cells that aid in the transmission of information between neurons, finds a new Yale research.

The Delta variant of SARS CoV2 maybe eight times less sensitive to antibodies generated by vaccines as compared to the original strain that came from China’s Wuhan, finds a recent study conducted in India.

India reported 43,965 fresh COVID-19 incidences and 930 deaths on Tuesday. The country has recorded 3,06,62,904 SARS CoV2 infections so far.

Researchers at the Stanford School of Medicine, US, and Saarland University in Germany have found that the brains of individuals who died of Covid-19 showed signs of inflammation and neurodegeneration, similar to that observed in people who die of conditions such as Alzheimer’s and Parkinson’s disease.

AstraZeneca India has joined hands with Docon Technologies, Bengaluru, for digitising 1,000 clinics across India. Under the partnership, Docon will equip the identified clinics with customised Electronic Medical Record (EMR) systems enabling clinicians to access complete patient history.

Indian pharmaceutical company, Mankind Pharma has partnered with Ace turtle to accelerate its omnichannel transformation in India

India reported 34,026 fresh COVID-19 incidences and 552 deaths on Monday. The country has recorded 3,06,18,939 SARS CoV2 infections so far. The overall fatalities from the pandemic have reached 4,03,310.

A new study published in Nature Medicine shows that genetically engineered yeast can respond to inflammation and successfully relieve inflammatory bowel disease (IBD) symptoms in mice. 

Research conducted by Kyushu University has found a possible genetic pathway behind the neurological dysfunction of Rett syndrome.

India reported 40,111 fresh COVID-19 incidences on Sunday. The country has recorded 3,05,84,872 SARS CoV2 infections so far. The overall fatalities from the pandemic has reached 4,02,758 with 725 deaths recorded on the day.

India reported 42,751 fresh COVID-19 incidences on Saturday. As many as 932 deaths were also recorded on the day taking the overall fatalities from the pandemic to 4,01,083.

Bharat Biotech’s Covaxin was found to be 77.8% effective against symptomatic COVID-19 and 93.4% effective against severe symptomatic COVID-19, according to the safety and efficacy analysis data from Phase 3 trial results.

A panel of healthcare experts convened by the Association of Physicians of India (API) has launched new therapy specific recommendations for teleconsultations in India. API has partnered with Abbott to share these recommendations with relevant stakeholders within the Indian healthcare ecosystem.

A new study from the University of Oxford in the United Kingdom has provided reassurance that a second dose of the Oxford-AstraZeneca vaccine remains highly effective even after a gap of up to 45 weeks.

India reported 44,176 fresh COVID-19 incidences on Friday. As many as 737 deaths were also recorded on the day taking the overall fatalities from the pandemic to 4,01,083. The country has recorded 3,05,01,725 SARS CoV2 infections so far.

Scientists in the Netherlands have found coronavirus is common in pet cats and dogs where their owners have the disease.

In its COVID-19 Weekly Epidemiological Update, The World Health Organization (WHO) has said the Delta variant of COVID-19 is now present in nearly 100 countries as per conservative estimates and warned that in the coming months the highly transmissible strain will become the dominant variant of the coronavirus globally.

Researchers at Texas Biomedical Research Institute (Texas Biomed) have narrowed down the proteins enabling SARS-CoV-2 to cause disease using advanced genetic engineering techniques.

Two Phase 1 clinical trials, conducted in the US, of a novel candidate malaria vaccine, have found that the regimen conferred unprecedentedly high levels of durable protection when volunteers were later exposed to disease-causing malaria parasites.

India reported 46,308 fresh COVID-19 incidences on Thursday. As many as 843 deaths were also recorded on the day taking the overall fatalities from the pandemic to 4,00,332.

India reported 48,415 fresh COVID-19 incidences on Wednesday. As many as 988 deaths were also recorded on the day taking the overall fatalities from the pandemic to 3,99,475.

Bharat Biotech’s Covaxin may effectively neutralise both Alpha and Delta variants of coronavirus, finds the US National Institute of Health study.

The Drugs Controller General of India (DCGI) gives emergency use nod to Moderna’s COVID-19 vaccine. Importing of the vaccines from the US will be facilitated by Indian drug pharma Cipla, under licence for restricted use by DCGI.

India reported 45,641 fresh COVID-19 incidences on Tuesday.As many as 816 deaths were also recorded on the day taking the overall fatalities from the pandemic to 3,98,484.

A recent study conducted by Mount Sinai researchers in Egypt found that multiple myeloma patients mount variable and sometimes suboptimal responses after receiving the Pfizer-BioNTech or Moderna COVID-19 vaccines.

A latest Oxford University study found that a third booster dose of the Oxford-AstraZeneca COVID-19 vaccine produces a strong immune response.

India reported 37,070 fresh COVID-19 incidences on Monday.As many as 907 deaths were also recorded on the day taking the overall fatalities from the pandemic to 3,97,668.

Researchers at the University of Nicosia in Cyprus modelled the spread of pollen from a willow tree through a nearby crowd of people and found that tree pollen could facilitate the transmission of the virus in a crowd of people gathered outdoors.

India may start Covid vaccination of children in the 12-18 age group by the end of July or first week of August, said Dr N K Arora, the head of the National Technical Advisory Group on Immunisation (NTAGI), the government’s Covid working group.

Intellia Therapeutics and partner Regeneron’s in vivo CRISPR/Cas9 genome editing candidate, NTLA-2001, showed positive interim results in patients with transthyretin (ATTR) amyloidosis.

India reported 46,521 fresh COVID-19 incidences on Sunday. The country has recorded 3,02,78,986 SARS CoV2 infections so far.

The Union ministry of health has informed that about 50 cases of Delta Plus variant of Covid-19 have been recorded across 11 states of India so far.

India reported 49,701 fresh COVID-19 incidences on Saturday. The country has recorded 3,02,32,320 SARS CoV2 infections so far.

A Reuters poll of medical experts showed that the third wave of coronavirus infections is likely to hit India by October, and although it will be better controlled than the latest outbreak, the pandemic will remain a public health threat for at least another year.

A study by the ministry of health of Argentina’s Buenos Aires province to monitor the safety of the Sputnik V vaccine claimed that the Russian vaccine against coronavirus, Sputnik V, has demonstrated the best safety profile among all vaccines used in the province.

The third wave of COVID-19 in India– if it occurs — is unlikely to be as severe as the second wave given the extent of spread of coronavirus infections that has already taken place in the country. A latest study report, authored by Sandip Mandal, Balram Bhargava and Samiran Panda from the Indian Council of Medical Research, and Nimalan Arinaminpathy from the Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, UK, was based on a mathematical modelling analysis and published in the Indian Journal of Medical Research.

The World Health Organization (WHO), World Intellectual Property Organization(WIPO) and the World Trade Organization (WTO), collaborated to tackle the COVID-19 pandemic and global challenges in the field of public health, intellectual property and trade.

India reported 48,768 fresh COVID-19 incidences on Friday. The country has recorded 3,01,82,619 SARS CoV2 infections so far.

In a new study using the Gamma variant of coronavirus recovered from patients, researchers in the US and Japan have found that vaccination with an mRNA vaccine induces antibody responses that would protect humans from infection with the gamma or P.1 variant.

The Maryland-based biotech firm Novavax announced its latest trial results of its vaccine NVX-CoV2373 against Covid-19, with an efficacy rate of more than 90 per cent even against the variants.

Researchers from Simon Fraser University (a public research university in British Columbia, Canada) is set to begin a new pandemic-related study comparing vaccine effectiveness in people living with HIV and those who do not have the condition.

India reported 51,659 fresh COVID-19 incidences on Thursday. The country has recorded 3,01,33,851 SARS CoV2 infections so far. The active infection load presently comprised 6,07,638 cases, according to data from the union health ministry

Research conducted by Oxford University and UK Coronavirus Immunology Consortium showed that the previous coronavirus infection does not necessarily offer protection against Covid in the longer duration, especially when caused by new variants of concern.

Axion Neuroscience, A leading clinical-stage biotech company, has published completed phase II clinical trial results where Alzheimer’s Vaccine AADvac1 was found to be most effective on the subgroup of patients with confirmed Alzheimer’s disease

A recent study published in Medical Hypotheses of Elsevier observes that that older adults who have received diphtheria or tetanus vaccine booster within the past 10 years may have a lower risk of severe COVID-19.

The Wyss Institute for Biologically Inspired Engineering, a cross-disciplinary research institute at Harvard University, announced that it is collaborating with multiple industry partners to discover more effective approaches to deliver drugs across the blood-brain barrier (BBB) for the treatment of brain diseases.

The World Health Organisation (WHO) has confirmed that the delta Covid variant, first detected in India, has already spread to more than 80 countries and is undergoing continuous mutations as it spreads across the globe.

India reported 54,286 new COVID-19 incidences on Wednesday. With as many as 1,323 fatalities recorded on the day, the overall number of deaths from the pandemic has escalated to 3,92,014.

India reported 50,817 fresh COVID-19 incidences on Tuesday. The country has recorded 3,00,27,883 COVID-19 cases so far. The active infection load presently comprised 6,37,903 cases, according to data from the union health ministry.

Apollo Proton Cancer Centre has recently inaugurated a temporary drive-through COVID vaccination camp.

India reported 42,683 fresh COVID-19 incidences on Monday. As many as 1,167 deaths were also recorded on the day taking the overall fatalities from the pandemic to 3,89,332. The country has recorded 2,99,77,066 COVID-19 cases so far.

The probiotic supplier, Probi and Oriflame have joined hands for a global launch of a new probiotic supplement focused on general gut health.

Apollo Hospitals Chennai has begun providing the anti-COVID vaccine Sputnik V.  The vaccine which is directly procured by Apollo Hospitals from Dr Reddy’s Laboratories will be available at a cost of INR 1,145 per dose, including administrative charges, announced the hospital.

India reported 52,956 fresh COVID-19 incidences on Sunday. As many as 1,423 deaths were also recorded on the day taking the overall fatalities from the pandemic to 3,88,164.

The US FDA has recently approved a new Alzheimer’s disease drug Aducanumab to be sold under the brand name Aduhelm (Biogen). It is the first new treatment approved for Alzheimer’s since 2003 and is the first therapy that targets the fundamental pathophysiology of the disease.

India reported 62,397 fresh COVID-19 incidences on Thursday. As many as 1,591 deaths were also recorded on the day taking the overall fatalities from the pandemic to 3,83,522.

India reported 67,289 fresh COVID-19 incidences on Wednesday. As many as 2,329 deaths were also recorded on the day taking the overall fatalities from the pandemic to 3,81,931.

Netherlands-based pharmaceutical company Byondis has announced positive topline results from the phase III TULIP study of its antibody-drug conjugate [vic-]trastuzumab duocarmazine in patients who were pretreated for HER2-positive unresectable locally advanced or metastatic breast cancer (MBC).

The Apollo Hospitals has started offering monoclonal antibody therapy for COVID-19 patients, who have mild symptoms and comorbidities.

India reported 62,176 fresh COVID-19 incidences on Tuesday. As many as 2,539 deaths were also recorded on the day taking the overall fatalities from the pandemic to 3,79,601.

India continued to witness a dip in the number of fresh COVID-19 incidences on Monday which stood at 60,008. As many as 2,733 deaths were also recorded on the day taking the overall fatalities from the pandemic to 3,77,062. The country has recorded 2,95,70,085 COVID cases so far.

India witnessed a dip in the number of fresh COVID-19 incidences on Sunday reaching 70,984. As many as 3,922 deaths were also recorded on the day taking the overall fatalities from the pandemic to 3,74,329.

Fresh COVID-19 cases dipped to 84,542 on Friday in India. The new fatalities recorded on the day stood at 3,996 taking the overall number of deaths from the pandemic to 3 ,67,106.

India reported 91,755 new COVID-19 incidences on Thursday. With as many as 3,412 fatalities recorded on the day, the overall number of deaths reported in the country due to the pandemic has reached 3,63,108.

A coalition of global health experts from the US has recently called on the Group of Seven (G7) leaders to share at least 1 billion, and aim for 2 billion vaccine doses to low- and middle-income countries by the end of 2021.

India reported 93,828 new COVID-19 incidences on Wednesday. With as many as 6,138 fatalities recorded on the day, the overall number of deaths reported in the country due to the pandemic has reached 3,59,695

US biotechnology company Verve Therapeutics has published its preclinical, proof-of-concept paper on the successful use of base editing to turn off a gene in the liver and thereby lower blood levels of either LDL cholesterol or triglyceride-rich lipoproteins, two factors leading to coronary atherosclerosis.

Dr Sandhya Bhullar has been appointed as the new secretary of the National Medical Council (NMC), India’s top medical regulator.

Demands have been growing for providing financial assistance to healthcare workers who get infected while treating COVID-19 patients.

India reported 92,791 new COVID-19 incidences on Tuesday. With as many as 2,222 fatalities recorded on the day, the overall number of deaths reported in the country due to the pandemic has reached 3,53,557.

India reported 85,803 new COVID-19 incidences on Monday. The country has reported 2,89,95,457 cases so far, according to data from the union health ministry.

India reported 1,01,159 new COVID-19 incidences on Sunday. The country has reported 2,89,09,604 cases so far, according to data from the union health ministry

India reported 1,20,332 new COVID-19 incidences on Friday. The country has reported 2,86,93,835 such cases so far, according to data from the union health ministry.

Apollo Hospitals has launched a new initiative named ‘Advanced COVID Care beyond Hospitals’ to provide medical care assistance to COVID-positive patients in quarantine at home.

The molecular diagnostics company Redcliffe Lifetech, has introduced a non-invasive (serum/fluid) RT-PCR test to detect the DNA of mucorales species causing mucormycosis or black fungus.

India reported 1,31,280 new COVID-19 incidences on Thursday. The country has reported 2,85,72,359 such cases so far, according to data from the union health ministry.

Medical technology company Trivitron Healthcare has launched two new high-performance liquid chromatography analysers NANO H5 & NANO H110 for detection of HbA1c and Hb variant.

India reported 1,34,044 new COVID-19 incidences on Wednesday. The country has reported 2,84,41,079 such cases so far, according to data from the union health ministry.

India reported 1,33,136 new COVID-19 incidences on Tuesday. The country has reported 2,83,06,971 such cases so far, according to data from the union health ministry. The active infection load presently comprised 17,89,437 cases.

India reported 1,26,649 new COVID-19 incidences on Monday. The country has reported 2,81,73,655 such cases so far, according to data from the union health ministry.

India reported 1,53,396 new COVID-19 incidences on Sunday. The country has reported 2,80,47,006 such cases so far, according to data from the union health ministry.

Signalling further delay in the release of the next batch of Covaxin, the Hyderabad-based manufacturer Bharat Biotech said on Friday that the production batches of the vaccine that were initiated during March this year will be ready for supply only during the month of June.

India reported 1,86,075 new COVID-19 incidences on Thursday. The country has reported 2,75,54,245 such cases so far, according to data from the union health ministry.

India reported 2,11,275 new COVID-19 incidences on Wednesday. The country has 2,73,67,935 such cases so far, according to data from the union health ministry.

The nanotechnology research-based biopharmaceutical company, VAV Life Sciences, is ramping up the production of crucial lipid ingredients essential for manufacturing liposomal amphotericin B, the drug used for treating mucormycosis also known as the black fungus infection.

Genotypic Technology Ltd has joined hands with Premier Medical Corporation (PMC) USA for distribution of rapid antigen and antibody kits in India.

India reported 2,08,714 new COVID-19 incidences on Tuesday. The country has reported  2,71,56,382 such cases so far, according to data from the union health ministry.

India reported 1,95,810 new COVID-19 incidences on Sunday. The total confirmed cases recorded thus far in the nation has climbed to 2,69,47,621, according to data from the union health ministry.

Bharat Parenterals’ favipiravir oral suspension has recently received approval from the Drugs Controller General of India (DCGI) for treatment of COVID-19 patients.

Bharat Biotech will soon begin clinical trials of its COVID-19 vaccine Covaxin on kids aged 2 to18 years from June 1, the Hyderabad headquartered vaccine maker had announced.

India reported 2,22,704 new COVID-19 incidences on Sunday. The total confirmed cases recorded thus far in the nation have climbed to 2,67,51,681, according to data from the union health ministry.

The Defence Research and Development Organisation (DRDO) has developed a new COVID-19 antibody detection kit called Dipcovan that offers results in mere 75 minutes, announced the defence ministry.

With 2,57,299 new coronavirus infections being reported on Friday, India’s tally of COVID-19 cases climbed to 2,62,88,080. The daily deaths were recorded at 4,194, taking the toll to 2,95,560, according to the union health ministry data.

Dedicated centres will be set up in Delhi for the treatment of black fungus or mucormycosis cases at three city government-run hospitals, announced the Delhi Chief Minister Arvind Kejriwal.

Cipla has launched a new RT-PCR test kit ViraGen in India.The company announced that the new test kit for COVID-19 will be commercialised in the country in partnership with Ubio Biotechnology Systems.

The real estate brand Runwal Group has tied up with the Fortis Hospitals and Apollo Clinic to offer prime healthcare services to the residents at their projects.

India reported 2,59,242 new COVID-19 incidences on Thursday. The total confirmed cases recorded thus far in the nation have climbed to 2,60,30,781, according to data from the union health ministry. The active infection load presently comprised 30,22,889 cases.

Indian Council of Medical Research (ICMR) has approved a testing device for CoViD-19 which can be used at home. Manufactured by Pune-based Mylab Discovery Solutions Ltd., the self-testing kit is called ‘CoviSelf’.

India reported 2,76,193 new COVID-19 incidences on Wednesday. With this, the total confirmed cases in the nation have climbed to 2,57,71,539, according to data from the union health ministry, while the active infection load comprised 31,25,056 cases

Apollo Hospitals Chennai has recently carried out a successful total femur replacement on a 11-year-old patient who was bedridden for months as the child suffered from osteosarcoma

Germany-based biopharmaceutical company Boehringer Ingelheim is making available a euro one million COVID relief fund to enable sustenance and livelihoods of underserved and tribal communities, and address the medical needs of patients in India, through the 2021-22 financial year.
 

US drug pharma Johnson and Johnson has joined hands with Telangana-based biopharmaceutical company Biological E for the manufacturing of their Janssen Covid-19 vaccine.

India has reported 2,67,246 new COVID-19 incidences on Tuesday. The nation has been showing a decline in its daily number of COVID-19 cases recently, although the number of deaths from the infection is still going up. As many as 4,530 fatalities were recorded during the day pushing the overall death toll due to the pandemic to 2,83,281.

ResMed’s statement on the ongoing COVID crisis in India. The following statement is from ResMed’s Asia & Latin America President Justin Leong:

The Hinduja Foundation has collaborated with the Chopra Foundation, the John W Brick mental health foundation, and CG Creatives, to co-sponsor Spotlight India, a three-hour segment within the Never Alone Global Mental Health (Virtual) Summit to promote the importance of mental health.

Singapore has announced today that it would be closing schools from Tuesday as a new coronavirus (SARS CoV-2)    strain like the one first detected in India were affecting more children in the city-state. The government has been tightening restrictions following a recent rise in local transmissions after months of near-zero cases.  

Former national president of the Indian Medical Association (IMA) and well known cardiologist Dr K.K. Aggarwal, 62, passed away due to complications related to COVID-19 at the All India Institute of Medical Sciences, Delhi, on Monday night.

The senior living community operator Columbia Pacific Communities (CPC), has joined Fortis Healthcare, to launch a ten-day mental wellness initiative titled #ReachOut to help senior citizens of India to address their mental health issues during the COVID-19 crisis.

India reported 2,63,021 new COVID-19 incidences and 4,334 fatalities on Monday. With this, the total confirmed cases in the nation has climbed to 2,52,28,100, according to data from the union health ministry.

Apollo Hospitals and Dr. Reddy’s Laboratories have announced the launch of a limited pilot programme for the Sputnik V vaccine as part of the soft launch by the company in India.

The US FDA has recently approved a new single 1000 mg dose of ferric carboxymaltose injection (Injectafer) for the treatment of iron deficiency anaemia (IDA) in adult patients.

A recent study conducted in collaboration with the National Institute of Virology and the Indian Council of Medical Research has demonstrated that the Covaxin vaccine could protect against the new SARS-CoV-2 variants.

India reported 2,81,837 new COVID-19 incidences and 4,095 fatalities on Sunday. With this, the total confirmed cases in the nation has climbed to 2,49,65,079, according to data from the union health ministry.

India reported 3,26,014 new COVID-19 incidences and 3,876 fatalities on Friday. With this, the total confirmed cases in the nation has climbed to 2,43,72,243, according to data from the union health ministry

Roche India has donated fifty thousand vials of tocilizumab (Actemra) 80 mg worth INR 40+ crores to the Ministry of Health and Family Welfare (MoHFW), Government of India to help patients during the pandemic, the company said in a statement.

Intra-articular injections of mesenchymal stem cells into the synovium may produce expression of a number of genes that can inhibit progression of osteoarthritis, demonstrated a study presented at the 2021 OARSI World Congress virtual meeting.

Dr. Reddy’s Laboratories has announced that the first consignment of imported doses of the Sputnik V has been soft launched and the first dose of the vaccine was administered in Hyderabad.

The biotechnology company Goldfinch Bio has initiated the phase 1 clinical trial of its GFB-024, a novel precision medicine product candidate for patients with severe insulin-resistant diabetic nephropathy (DN).

Apollo Hospitals has launched a free tele-access facility that general physicians and nursing homes can use to get advice from critical care experts on the treatment of COVID-19 patients.

India reported 3,43,005 new COVID-19 incidences and 4,000 fatalities on Thursday. With this, the total confirmed cases in the nation has climbed to 2,40,46,229, according to data from the union health ministry.

The US FDA has recently approved Johnson and Johnson’s Acuvue- Abiliti overnight therapeutic lenses for the management of myopia. The orthokeratology (ortho-k) contact lens is developed by Johnson & Johnson Vision, a part of the Johnson & Johnson medical devices companies.

With a spike in the new incidences of COVID-19 in India, hospitals have also been reporting a rare infection of mucormycosis, also called as black fungus, among people recovered from COVID-19. The infection is caused by exposure to mucor mould and it affects the sinuses, the brain and the lungs and may be life-threatening.

Due to the unprecedented rise in COVID-19 cases in India, the Centre has announced an agreement permitting its employees with recognised qualifications to undertake medical practice or teleconsultation.

Council of Scientific and Industrial Research (CSIR) has clarified that media reports stating people with AB and B blood groups are more susceptible to CoViD-19 than other blood groups, citing a survey conducted by CSIR, is actually false propaganda.

The expert panel that advises the Indian drug regulator has recommended phase II and III trials for Covaxin on children aged between two and 18 years.The nod from the subject expert committee (SEC) to conduct trials will allow the evaluation of the safety, reactogenicity and immunogenicity of Covaxin on kids.

India reported 3,62,632 new COVID-19 incidences and 4,128 fatalities on Wednesday. With this, the total confirmed cases in the nation went past 2.37 crores reaching 2,37,03,224, according to data from the union health ministry.

India’s CoViD-19 tally reached 2,33,40,938 on Wednesday with 3,48,421 fresh cases reported in the last 24 hours. The country recorded one of its highest single-day death tolls by the pandemic at 4,205 on the day taking the total deaths so far to 2,54,197. According to the Health Ministry data, the active cases have reduced to 37,04,099 […]

India’s drug regulator–Drug Controller General of India–has approved use of anti-fungal drug liposomal amphotericin B or LAmB as a treatment against Mucormycosis.

Generic drugmaker Cipla has signed a licensing agreement with Eli Lilly and Co., to manufacture and sell the latter’s arthritis drug baricitinib, now repurposed as a drug for the treatment of CoViD-19.

China-based Sinopharm’s CoViD-vaccine has recently been granted the ‘Emergency Use Approval’  by the WHO. China has already used the Sinopharm-vaccine to immunize millions of people there. In addition to China, UAE, Pakistan and Hungary are already using the vaccine.

In another grim milestone, India witnessed 4,192 new COVID-19 related deaths on Friday pushing the overall fatalities to 2,38,266. The country recorded 4,01,342 new COVID-19 cases on the day. With this, the total confirmed cases soared to 2,18,86,725 in the country.

With the country witnessing the second wave of COVID-19 pandemic, doctors, who have been waging a long-drawn battle against the disease along with other healthcare workers for more than a year, find themselves up against the VIP culture prevalent in government hospitals and have urged Prime Minister Narendra Modi to take measures to rein in the same.

India recorded 4,14,280 new COVID-19 cases on Thursday. The country also recorded  3,923 new deaths on the day taking the overall fatalities to 2,34,074.

World Health Organization (WHO) will be setting up a Data-hub for Pandemic and Epidemic Intelligence, in Berlin, Germany.

Russia has authorized the use of Sputnik Light, the single dose vaccine against CoViD-19. Sputnik Light is actually the first component of the Sputnik V vaccine, developed and released by Russia, earlier. This first component contained in Sputnik Light is the Recombinant Human Adenovirus Serotype Number 26 (rAd26).

According to Roche India, it has received ‘Emergency Use Authorization’ (EUA) for its investigational drug combination, Casirivimab and Imdevimab, for the treatment of CoViD-19 patients in India. T

Union Health Ministry has cautioned that a third phase of the coronavirus pandemic is “inevitable”, but it is not clear on what time and scale this phase would occur and hence, we should be prepared for the same.

With a record spike in fresh cases of Covid-19, India recorded 4,12,262 new cases and 3,980 deaths in the last 24 hours. The Union health ministry said on Thursday that the total number of patients infected with the novel coronavirus so far stands at 21.07 million and 3,29,113 discharged during the same time period.

In a grim milestone, India once again recorded over 4 lakh new COVID-19 on Wednesday. The country which reported 4,12,624 new cases also saw 3,979 new deaths on the day taking the overall fatalities to 2,30,151.

According to the latest guidelines issued by World Health Organization, there is a possibility for airborne transmission of SARS-Co-V-2 leading to CoViD-19. This declaration from WHO was a long-awaited one, as a study report published in the Lancet journal was already in news captions, even a week before.

Drugs that inhibit Hepatitis C virus protease-inhibitor can be used to treat CoViD-19 alongside Remdesivir, according to a new study conducted at University of Texas and Icahn School of Medicine in US.

India reported 3,82,847 new COVID-19 cases on Tuesday. As many as 3,786 deaths were reported on the day taking the overall fatalities to 2,26,172. The total confirmed cases soared to 2,06,58,479 in the country. The active infection load comprised 34,84,915 cases.

Apollo Hospitals has recently performed a breakthrough surgery on a woman who was affected by idiopathic scoliosis, an abnormal curvature of the spine. The team led by Dr Sajan K Hegde from Apollo successfully carried out the surgery which is known as fusion-less scoliosis surgery on the patient.

India reported 3,55,769 new COVID-19 cases on Monday. As many as 3,439 deaths were reported on the day taking the overall fatalities to 2,22,386. The total confirmed cases soared to 2,02,75,632 in the country. The active infection load comprised 34,43,624 cases.

London-based Hikma Pharmaceuticals have received the FDA approval to market a higher dose of naloxone hydrochloride spray (Kloxxado) for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression, for adult and paediatric patients.

India reported 3,70,188 new COVID-19 cases on Sunday. During the past weeks from April 26-May 2 India posted the highest number of new cases globally over a seven-day period for the second week with nearly 22.5 lakh cases.

India reported more than 4 lakh new COVID-19 cases reaching 4,02,014 on Friday. Every day, more than three lakh cases have been recorded in the country for the past few weeks, making India one of the worst-hit countries in the world.

The government of India has started importing the drug Remdesivir from other countries to ease its shortage in the country. The government has placed orders for procuring 4.5 lakh vials of Remdesivir.

The US Food and Drug Administration (FDA) has approved the drug Dapagliflozin for adult patients with chronic kidney disease (CKD) at the risk of disease progression. The drug marketed by AstraZeneca as Farxiga is expected to reduce the risk for kidney function decline, kidney failure, cardiovascular death, and hospitalization for heart failure in adult patients with CKD.

The digital healthcare platform PharmEasy has launched the COVID-19 vaccination drive in India with an aim to vaccinate over 3 crore people via camps and vaccine centres. Individuals, companies, RWAs and old Age homes can also register for vaccines that will be administered.

French biotech company Valneva has launched a Phase III Cov-Compare (VLA2001-301) clinical trial of its inactivated Covid-19 virus vaccine candidate, VLA2001.

India recorded 3,79,280 fresh COVID-19 cases on Wednesday. As many as 3,646 deaths were reported on the day taking the overall fatalities to 2,04,812.

India continued to report fresh COVID-19 cases above 300,000 for the sixth day in a row on Wednesday. The head of the World Health Organization, Tedros Adhanom Ghebreyesus, called the situation in India “beyond heartbreaking” and warned that many countries in the world “are still experiencing intense transmission,” with more new cases globally in the past week than in the first five months of the pandemic.

California-based healthcare company VeeMed has decided to offer its assistance through telemedicine technology and physician services cost-free to assist India amid the country’s public health emergency caused by the COVID-19 outbreak.

India recorded 3,19,460 fresh COVID-19 cases on Monday. As many as 2,762 deaths were reported on the day taking the overall fatalities to 1,97,880.

India recorded 3,54,653 fresh COVID-19 cases on Sunday. As many as 2,808 deaths were reported during the day taking the overall fatalities due to the pandemic to 1,95,118.

India’s drug regulator has recently given restricted emergency use approval for the use of pegylated interferon alpha-2b (PegIFN) branded as Virafin, in treating moderate Covid-19 infection in adults, announced Zydus Cadila.

India recorded 3,44,949 fresh COVID-19 cases on Friday. As many as 2,620 deaths were reported during the day taking the overall fatalities due to the pandemic to 1,89,549.

Alembic Pharmaceuticals has received the USFDA approval for its abbreviated new drug application (ANDA) doxepin hydrochloride capsules usp, 10 mg, 25 mg, 50 mg, 75 mg and 100 mg.

India’s biopharmaceuticals manufacturing company, VAV Lifesciences, through its subsidiary VAV Lipids, has signed an MOU with US-based multinational contract development and manufacturing organization (CDMO) to produce and supply highly purified synthetic phospholipids suitable for vaccine manufacturing.

India recorded 3,32,518 fresh COVID-19 cases on Thursday. As many as 2,257 deaths were reported during the day taking the overall fatalities due to the pandemic to 1,86,929.

India recorded a grim milestone of fresh COVID-19 cases surpassing 3 lakh incidences reaching 3,15,735 on Wednesday.

India reported one of the highest spikes in COVID-19 cases crossing over 2.94 lakh on Tuesday. As many as 2,020 deaths were also reported during the day taking the total fatalities to 1,82,570

India, on Monday, reported more than 2.5 lakh fresh COVID-19 cases and 1,757 deaths. The overall fatalities due to the pandemic have reached 1,80,550 in the country.

Apollo Proton Cancer Centre has recently launched its dedicated robot-assisted cancer surgery unit to offer patients with comprehensive cancer care under one roof. The centre also completed its first robotic procedure on a 40 year old patient with colon cancer.

In a study published in the Nature journal Communications Biology on April 12th, 2021, an international team of researchers led by MedGenome, India/USA and SciGenom Research Foundation(SGRF), India analyzed genetic variation in ACE2, the receptor for the COVID-19 causing SARS-CoV-2 virus, from over 300,000 individuals and identified key mutations that are predicted to make individuals more susceptible to the COVID-19 virus.

With more than 2.7 lakh fresh cases and 1,620 deaths reported only in the past 24 hours, the COVID-19 cases continued to soar in India

Selpercatinib (Retevmo) treatment showed promising new antitumour activity and safety in various RET fusion-positive advanced solid tumours, according to Eli Lilly and Company’s phase I/II LIBRETTO-001 trial results.

India, on Friday, reported a new record single-day rise of 2,34,002 COVID-19 cases. This pushed the total confirmed case tally to reach 1,45,21,928. The active infection load soared to 16,73,214.

The use of two virus-neutralising antibodies casirivimab and imdevimab was found to reduce the risk and burden of COVID-19 infection, according to results from the phase III REGN-COV 2069 trial.

Dr. P R Sodani has taken over as President (Vice Chancellor) of IIHMR University, India’s pioneering academy in healthcare management, education and research.

India reported one of the highest spike of 2,16,828 fresh COVID-19 incidences on Thursday. The new cases pushed the total case tally of the nation to 1,42,87,926, while the active infection load soared to 15,63,702. So far, 1,74,335 people lost their lives to COVID-19 pandemic in the country. As many as 1,17,897 discharges and 1,182 deaths were recorded yesterday.

India, on Wednesday, reported fresh COVID-19 incidences surpassing the 2 lakh mark reaching 2,00,739. The new cases pushed the total case tally of the nation to 1,40,74,564, while the active infection load soared to 14,65,877. So far, 1,73,152 people lost their lives to COVID-19 pandemic in the country. As many as 93,418 discharges and 1,037 deaths were recorded yesterday.

Russia’s COVID-19 vaccine Sputnik V, which has received the restricted emergency use approval from the Drug Controller General of India (DCGI), may be made available for use in India by mid-May.

AstraZeneca’s (AZ) diabetes and heart failure drug dapagliflozin (Farxiga) did not produce significant results in its phase 3 DARE-19 trial conducted for treating high-risk patients hospitalised with COVID-19, announced the company.

India reported 1,60,694 fresh COVID-19 cases on Monday. The new cases pushed the total case tally of the nation to 1,36,86,073, while the active infection load soared to 12,58,906.

The use of oncolytic virus therapy using a modified herpes simplex virus (HSV) may help improve the overall survival of children with recurrent or progressive high-grade glioma after therapy, according to a study presented at the American Association for Cancer Research Annual Meeting.

India recorded 1,68,912 new COVID-19 cases on Sunday, pushing the country’s caseload to 1,35,25,389, which is now the second-highest number of infections globally after the US.

While recent reports from the European regulatory agency show that Oxford-AstraZeneca COVID-19 shot may be linked to rare blood clotting events, researchers are exploring causes that might be leading to the clotting side effects in these people.

New reports on a plausible link between AstraZeneca’s COVID vaccine and rare blood clotting issues in adults have prompted the Indian government to investigate on the case as the country is now counting on vaccinations to help contain its recent surge in COVID-19 cases.

Zydus Cadila has received USFDA approval for marketing its generic ibrutinib capsules. The drug is available in 70 mg and 140 mg.

Treatment with high-frequency spinal cord stimulation when added to conventional medical management could help in pain relief and improvements in quality of life among patients with refractory peripheral diabetic neuropathy, finds a new study published in JAMA Neurology.

Impelsys Inc., a global market leader in delivering impactful and adaptable online learning solutions, has announced that its online medical professional training platform iPC Health has partnered with RCNi to bring to India a continuing professional development (CPD) Programme for Nurses.

A new once-weekly insulin injection showed similar efficacy and safety and a lower rate of low blood sugar episodes when compared with a daily insulin, according to a phase 2 clinical trial.

Following the detection of a possible link with the Oxford-AstraZeneca  COVID-19 jab and rare blood clots in adults in the UK, the university has decided to halt the trial which was being carried out in children.

India again reported above 1 lakh COVID-19 cases reaching 1,15,262 on Tuesday. The new infections pushed the total case tally of the nation to 12,799,746.

Early treatment with anti-vascular endothelial growth factor (VEGF) injections may slow diabetic retinopathy, according to results from a recent intermediate study published in JAMA Ophthalmology. However, the treatment’s effect on vision, including changes in visual acuity and vision loss,  was similar to standard treatment which usually begins only after the onset of late disease.

Components of calcium channels play a decisive role in the formation of excitatory synapses, according to the findings of researchers from the Mental Health & Neuroscience research programme at the Karl Landsteiner University of Health Sciences in Krems, Austria (KL Krems).

CEPI, the Coalition for Epidemic Preparedness Innovations, launched a call for proposals to develop broadly protective SARS-CoV-2 vaccines and broadly protective Betacoronavirus vaccines.

The National Institutes of Health has initiated the phase 1 trial of a new investigational vaccine known as mRNA-1273.351 designed to protect against the B.1.351 SARS-CoV-2 variant first identified in South Africa.

The daily COVID-19 cases in India soared past 1 lakh reaching 1,03,794 on Sunday. The new infections pushed the total case tally of the nation to 12,587,921.

TechInvention Lifecare India has joined hands with biopharmaceutical company Eubiologics, South Korea, to launch Euvichol-Plus, a cost-effective oral cholera vaccine available in low density polyethylene (LDPE) unidose pack.

India recorded the highest spike of COVID-19 cases this year at 89,129 and 714 related deaths, on Friday. The surge is the highest since 20 September 2020 when 92,605 cases were reported.

India recorded a spike of 53,237 new COVID-19 incidences on Tuesday, pushing the total case tally of the nation to 12,148,599. While the overall number of recoveries have reached 11,432,077 the death toll increased to 162,502.

India recorded a spike of 68,206 new COVID-19 incidences on Sunday, pushing the total case tally of the nation to 12.039,210. 

India recorded a spike of 62,276 new COVID-19 incidences on Friday, pushing the total case tally of the nation to 11,908,373. While the overall number of recoveries have reached 11,292,849 the death toll increased to 161,275.

India recorded a spike of 59,069 new COVID-19 incidences on Thursday, pushing the total case tally of the nation to 11,846,082. While the overall number of recoveries have reached 11,262,503 the death toll increased to 160,983. The active caseload now crossed 4 lakh mark reaching 417,813, according to the data from the union health ministry.

The Indian SARS-CoV-2 Consortium on Genomics (INSACOG) recently detected a new “double mutant” variant of the COVID-19 causing coronavirus in the nation. Officials are checking if the new variant, where two mutations rise together in the same virus, maybe more infectious or less affected by vaccines.

India recorded a massive new spike in daily COVID-19 incidences on Wednesday, as the cases crossed 50,000 mark reaching 53,419.

Patients waiting for elective surgery should get COVID-19 vaccines ahead of the general population potentially helping to avoid thousands of post-operative deaths linked to the virus, according to a new global study conducted by the University of Birmingham.

India recorded 47,262 fresh COVID-19 cases on Tuesday taking the nationwide tally to 11,734,058, according to the union health ministry data. The death toll has reached 160,441 with 275 more people succumbing to the disease on the day

India registered 40,715 fresh COVID-19 infections on Monday taking the tally to 11,686,796, according to the union health ministry data. The number of active infections remained above three-lakh mark reaching 334,646.

India recorded over 2.6 lakh fresh COVID-19 cases in the past week (March 15-21). The nation reported new incidences reaching 47,009 on Sunday. With this, the total tally of cases went up to 1,16,45,719, while the active caseload comprised 3,31,671 cases, according to the union health ministry data.

India witnessed a new spike in COVID-19 incidences after registering 40,906 new cases on Friday. The total tally of cases went up to 11,554,895, while active caseload comprised 285,449 cases, according to the union health ministry data.

Estonia-based e-health innovator company, Viveo Health, recently joined hands with Voll Sante, a functional foods firm based in Mumbai, to promote nutritional and physical therapy in India.

Nine of the countries which represent 60% of the global TB burden saw more than a 20% decline in diagnosis and treatment of TB infections in 2020, according to the data shared by the Stop TB Partnership.

India witnessed yet another fresh spike in COVID-19 incidences after registering 39,643 new cases on Thursday. The total tally of cases went up to 11,513,945, while active caseload comprised 2,68,338 cases, according to the union health ministry data.

The Apollo Hospital, Chennai had recently successfully completed four back-to-back MitraClip procedures in a single day, achieving a milestone that is first in the Asian continent, according to a press release.

ResMed has launched “onesleeptest”, a new at-home sleep test by Ectosense, in India, in conjunction with World Sleep Day on March 19, to help patients and physicians diagnose people suffering from undiagnosed sleep apnea.

Marking one of the highest COVID-19 spikes in 2021, India reported 35,871 new incidences on Wednesday, March 17. With the new cases, the total COVID-19 infection tally rose to 11,474,605, while the active infections totalled 249,197 cases.

India recorded a new spike of COVID-19 incidences reaching 28,903 on Tuesday. The total tally of cases went up to 11,438,464, while active caseload comprised 231,335 cases, according to the union health ministry data. The death count increased to 159,079 with 187 daily new fatalities.

India recorded a total of 24,437 new COVID-19 infections on Monday. The total tally of cases went up to 11,409,595, while active caseload comprised 220,401 cases, according to the union health ministry data.

India recorded 26,291 new COVID-19 cases on Sunday taking the country’s infection tally to 11,3,85,339, according to union health ministry data.

India recorded a total of 24,845 new COVID-19 infections on Friday. The total tally of cases went up to 11,333,491, while the active caseload comprised 199,022 cases, according to the union health ministry data.

CEPI, the Coalition for Epidemic Preparedness Innovations, launched a US$3.5bn plan to reduce or even eliminate the future risk of pandemics and epidemics, potentially averting millions of deaths, and trillions of dollars in economic damage.

India recorded a total of 23,285 new COVID-19 infections on Thursday. The recovery rate has increased to 96.86 per cent, the data stated.

The Clinton Health Access Initiative (CHAI) and the American Cancer Society (ACS) has joined hands to expand the cancer access partnership (CAP) to enhance access to lifesaving cancer treatments in low- and middle-income countries in Asia and Africa.

The drug controller of India (DCGI) has approved osimertinib (Tagrisso) for adjuvant treatment in patients with non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations, announced Astra Zeneca.

India reported 21,814 new COVID-19 cases on Thursday pushing the total confirmed case tally of the nation to 11,284,311. The active infections went up to 1,85,665.

L V Prasad Eye Institute (LVPEI) Network Eye Banks has hit another milestone by providing 40% of the corneas distributed throughout India for sight-restoring corneal transplant surgeries last year.

India reported 16,846 new COVID-19 cases on Tuesday. With this, the total caseload of the nation rose to 11,261,470 of which active cases totalled 1,81,143.

India reported 15,388 new COVID-19 cases on Monday pushing the total confirmed case tally of the nation to 11,244,624. The active infections went up to 184,555.

India added 18,650 fresh COVID-19  cases on Sunday. With this, the total confirmed case tally rose to 11,229,398. The active cases registered an increase reaching 184,523.

India reported 18,292 fresh coronavirus cases on Friday. The total confirmed case tally has climbed to 11,191,864, while the number of active cases totalled 177,389.

Upping the ante against the move to promote “mixopathy” and allow ayurvedic practitioners to perform surgeries, Indian Medical Association (IMA), the largest body of practitioners of modern medicine in the country, has launched a massive campaign to counter the move.

India reported 16,838 fresh coronavirus cases on Thursday. The total case tally has climbed to 11,173,761, while the number of recoveries has surged to 10,839,894, according to data updated by the union health ministry

Apollo Speciality Hospitals recently performed a successful management of severe multiple traumatic injuries on a 20 year old man who accidentally fell from the 17th floor of a construction site.

Injecting a newly developed formulation of radioactive bone cement into bone could provide support and local irradiation for tumours, according to a study led by University of California, Irvine researchers.

Dozee has announced the launch of Dozee Pro, a contactless vitals monitor for hospitals. The new AI-powered triaging system is designed to convert any bed into a step-down ICU in under 2 minutes and enable remote monitoring of patients outside of the ICU, according to the company.

India reported a spike of 17,425 new COVID-19 cases on Wednesday. The new incidences pushed the national case tally to 11,156,748.

India’s Bharat Biotech, the maker of the whole virion inactivated COVID-19 vaccine–COVAXIN, announced its first interim analysis of BBV152, the vaccine fully developed and manufactured in India, on Wednesday (3rd March).

Estonia-based digital health firm Viveo Health, has recently been selected for the Mastercard Lighthouse MASSIV program, as the company aims to offer affordable healthcare to 1 billion people by 2025.

India reported 14,997 fresh COVID-19 cases on Tuesday. With this, the case tally went up to 1,11, 39,516, according to the health ministry data

India has entered the next phase of the vaccination drive for the age-appropriate population of people above 60 years of age and those over 45 years with comorbidities against COVID-19 on March 1.

India reported 12,286 fresh coronavirus cases on Monday pushing the tally to 1,11,24,527. The total active infections now stand at 1,65,207.

India, on Sunday, registered 15,616 fresh COVID-19 cases, taking its total confirmed caseload to 11,112,056.

India registered over 16,488 fresh COVID-19 cases on Friday. With this, India’s caseload has risen to 1,10,79,979. The active case count has further increased to 1,59,590, which comprises 1.44% of the total infections, according to the latest union health ministry data.

Tata STRIVE and Wipro GE Healthcare has joined hands to skill youth for jobs in the healthcare sector over a period of three years. The partnership aims to address the increasing demand for allied healthcare professionals (AHPs) who could make a significant contribution to the healthcare delivery system.

India recorded over 16,577 new COVID-19 infections on Thursday. The death toll has increased to 1,56,825 with 120 new fatalities, according to the data from the union health ministry.

Apollo Hospitals, Chennai recently performed a fast track total knee replacement surgery on a 66-year-old lady who was diagnosed with severe grade 4 osteoarthritis of knee joint with associated deformity.

India reported 16,738 new COVID-19 cases on Wednesday. The total active infections across the country now stand around 1,51,708 while the overall confirmed cases totalled 11,046,914, according to the data from the union health ministry.

India reported 13,742 fresh COVID -19 cases on Tuesday. The total confirmed cases have climbed to 1,10,30,176, while the number of recoveries surged to 1,07,26,702, according to the union health ministry

India recorded 10,584 fresh cases on Monday, pushing its overall confirmed case tally to 1,10,16,434. Meanwhile, the active cases went past the 1.5 lakh mark again after a gap of 17 days, according to union health ministry data on the day.

Combination therapy of pembrolizumab (Keytruda) and lenvatinib (Lenvima)  demonstrated a significant and clinically meaningful improvement in progression-free survival in first-line advanced renal cell carcinoma (RCC) patients, according to results from the phase III CLEAR study.

The Apollo Hospitals Group has recently joined hands with the Anatomiz3D Medtech Pvt Ltd, to establish hospital 3D-printing labs in India for three dimensional printed implants that would enable doctors to visualise and print implants for complicated cases

The Kochi-based Pharma Research company PNB Vesper life science Pvt has reportedly completed the phase IIb clinical trials of its proprietary drug, PNB-001 (GPP-Baladol), on COVID-19 patients.

India reported 13,979 new COVID-19 incidences on Sunday. The total confirmed cases have risen to 1,10,05,071, while the active infections remained at 1,47,100. The nation saw 9,476 recoveries and 79 deaths from the infection in the past 24 hours. The total recoveries have surged to 1,06,97,014, while the death toll went up to 1,56,418.

The Hyderabad- based multi-speciality tertiary care center, Global Hospitals recently performed haploidentical stem cell transplant on an eight years old child suffering from acute leukaemia.

India reported 13,993 new COVID-19 cases on Friday pushing the nation’s total caseload to 1,09,77,387. The active infections stood at 1,40,066 lakhs. The overall recoveries have risen to 1,06,75,882, after recording 9,962 discharges in the past 24 hours. The death toll has risen to 1,56,240 after reporting 90 new fatalities.

India’s tally of COVID-19 cases rose to 1,09,63,394 with 13,193 new incidences reported on Thursday. The recoveries have surged to 1,06,67,741 and the total fatalities increased to 1,56,111, according to the union health ministry data.The active infections stood at 1,36,632.

India reported 12,881 new COVID-19 incidences on Wednesday. The total caseload has risen to 1,09,50,201. The total number of active infections remained at 1,37,342.

The global Biotechnology and Life Sciences forum, BioAsia, organised by the Government of Telangana, has announced that the Genome Valley Excellence Award for the year 2021 will be presented to Bharat Biotech International for its breakthrough, pioneering research, development and commercialization of vaccines including Covaxin.

Once weekly administration of the type-2 diabetes drug semaglutide (Ozempic) was linked to a sustained, clinically relevant reduction in body weight in obese adult participants in the STEP 1 clinical trial, according to the Northwestern University Feinberg School of Medicine, US.

With 11,610 fresh cases, India’s COVID-19 tally has climbed to 1,09,37,320 on Tuesday, according to the union health ministry. The number of recoveries has surged to 1,06,44,858 taking the recovery rate to 97.33%. The active cases stood at 1,36,549.

A team of doctors at Fortis Hospital, Noida recently performed a lifesaving brain surgery using ‘clipping technique’ on a 50 years old woman who had a brain haemorrhage caused by a burst of an aneurysm in the brain.

AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age and older, including those over 65.

India’s COVID-19 case tally rose to 1,09,25,710 with 9,121 new infections reported on Monday, according to the union health ministry data. The active cases declined to 1,34,033 as the recoveries increased to 1,06,30,892. The death count rose to 1,55,813 with 81 daily new fatalities. As many as 11,576 patients were discharged on the day.

Apollo Cancer Centres at Theynampet has recently performed a new minimally invasive procedure of tubeless video-assisted thoracoscopic surgery (VATS).

The US FDA has approved trilaciclib (Cosela) for reducing the frequency of chemotherapy-related bone marrow suppression in adults with extensive-stage small cell lung cancer, announced the G1 Therapeutics.

India reported 11,431 new COVID-19 cases on Sunday. The country also saw 9,267 discharges and 87 deaths on the day. The total confirmed cases have reached 1,09,16,172 while the active infections now stand at 1,36,800. The overall recoveries reported so far have reached 1,06,19,083, and the death toll has mounted to 1,55,764.

With 12,143 new infections reported on Friday, India’s tally of COVID-19 cases rose to 1,08,92,746. The active cases stood at 1,36,571 which account for 1.25 per cent of the total cases. The total recoveries crossed 1.06 crore, to reach 1,06,00,625, taking the recovery rate to 97.32 per cent according to union health ministry data. The total deaths due to the pandemic has reached 1,55,550 with 103 new fatalities.

India reported 9,353 new COVID-19 incidences on Thursday, pushing the total case tally to 1,08,80,413. The active infections stood at 1,33,086. The recoveries rose to 1,05,87,351 with 15,722 new discharges, pushing the national recovery rate to 97.32 per cent, according to union health ministry data.

One out of every four oncologists is willing to include palliative care services within their treatment protocols, according to a survey finding conducted online with 200 oncologists across India in early January 2021.

India reported 12,539 new COVID-19 incidences on Wednesday. With this, the total caseload of the state has climbed to 1,08,71,060. The number of recoveries has surged to 1,05,71,629, after recording 11,796 discharges in the past 24 hours, the health ministry said on Thursday.

India reported 11,067 positive COVID-19 cases on Tuesday. With this, the total caseload has escalated to 1,08,58,371, of which the active cases remained at 1,41,511. As many as 13,087 discharges and 94 deaths from the infection were reported in the last 24 hours, according to the union ministry of health. The total recoveries have reached 1,05,61,608 and the death toll went up to 1,55,280 till now.India has been recording less than 150 daily COVID-19 deaths since January 30.

India reported 8,689 new COVID-19 infections pushing the case tally to 1,08,47,790. The active infections stood at 1,41,118, as of now. With 13,575 new discharges, the total recoveries have escalated to 1,05,46,905. As many as 77 deaths took the total fatalities to 1,55,195.

AstraZeneca India has received marketing authorisation for their anti-diabetic drug dapagliflozin, in India for the treatment of patients of chronic kidney disease (CKD) up to stage III.  

The US FDA has recently approved tepotinib (Tepmetko) for the treatment of adults with metastatic non-small cell lung cancer (NSCLC) harbouring mesenchymal–epithelial transition exon 14 (METex14) skipping alterations.

Indian Medical Association (IMA), the largest body of allopathic practitioners in the country, has come out in support of the government’s COVID-19 vaccination drive and requested all its 3.5 lakhs members to get vaccinated voluntarily.

India reported 12,401 new COVID-19 incidences on Thursday. The total active infections stood at 1,48,750 while the overall positive cases recorded so far has elevated to 1,08,03,533. The total recoveries have reached 1,04,95,401, with 15,888 of them getting discharged yesterday. With 120 recent deaths, the total fatalities have climbed to 1,54,862.

Clinical trials testing a broadly neutralising antibody VRC01 have come out with the finding that the single agent could not significantly stall the transmission of HIV.

Initial signs of a recurrence of glioblastomas could be detected more than six months earlier than otherwise possible using standard clinical methods, according to a study by researchers from Karl Landsteiner University of Health Sciences in Krems.

India reported 12,916 new COVID-19 incidences on Wednesday. The total case tally has now reached 1,07,91,123. The active infections stood at 1,52,360. As many as 17,808 patients got discharged in the past day taking the total recoveries to 1,04,79,508. With 107 recent deaths, the total fatalities climbed to 1,54,742, till now.

The Bengaluru-based Neuome Technologies has announced the development and launch of Nemo, an ambient air quality monitoring device for detecting SARS-CoV-2.

Early integration of palliative care can improve the quality of life of cancer patients and their families, experts said.

One in two residents in Delhi has been exposed to the coronavirus and developed antibodies for the infection, according to the fifth serological survey conducted by the Delhi government. The city is now inching towards herd immunity, but people should not let their guard down, stated the Delhi health minister Satyendar Jain. However, people should still take vaccines as it will provide a better immune response against the virus and also continue to take all precautions.

India, on Tuesday, reported 11,039 new COVID-19 incidences. With this, the total case tally has risen to 1,07,78,206, of which 1,57,355 are active infections. The total recoveries have reached 1,04,61,706, with 14,256 new discharges recorded yesterday. As many as 113 deaths took the total fatalities to 1,54,635.

India recorded 8,635 new cases of coronavirus disease in the last 24 hours, according to the union health ministry. With this, the nationwide tally reached 1,07,67,206. The active cases stood at 1,60,728. The total recoveries have reached 1,04,47,450 with 13,443 new discharges reported in the past day. With 94 recent deaths, the total fatalities have reached 1,54,522.

Union finance minister Nirmala Sitaraman announced a total additional spend of Rs 2.23 lakh crore on “healthcare and well being” as part of Union Budget 2021, including Rs 35,000 crore for COVID-19 vaccine development and inoculation. 

India reported 11,427 new coronavirus cases on Sunday pushing the nation’s tally to 1,07,57,610. While the number of people who have recuperated from the disease has surged to 1,04,34,983, according to the union health ministry data. The COVID-19 active cases remained below 2 lakh at 1,68,235. The national recovery rate surged to 97%. The death toll increased to 1,54,392 with 118 daily new fatalities. The COVID-19 case fatality rate stands at 1.44%. The health ministry stressed that more than 70% of the deaths occurred due to comorbidities.

India witnessed 13,053 fresh cases of COVID-19 on Friday. The total number of active cases in the country has fallen to 1,67,316, while the caseload tally stands at 1,07,34,026. With 14,872 new discharges recorded yesterday, the total recoveries have escalated to 1,04,08,034, till now. Meanwhile, the death toll has reached 1,54,184, with 137 recent deaths.

India saw 18,910 fresh COVID-19 infections on Thursday pushing its cumulative caseload to 1,07,20,971. The total active infections now stand at 1,69,284. With 20,315 new discharges recorded on the day the total recoveries have risen to 1,03,93,162. The death toll has mounted to 1,54,047, with 162 new fatalities.

India reported a total of 11,556 new COVID-19 cases on Wednesday. The total caseload of the country now stands at 1,07,02,031, of which 1,70,856 are active infections. The total number of recoveries have reached 1,03,72,818, till now, of which 14,261 discharges were recorded yesterday. With 123 new fatalities, the death toll escalated to 1,53,885.

The Breast International Group (BIG), a not-for-profit organisation for academic breast cancer research groups from around the world, is paving the way towards more personalised treatment of breast cancer with its large network of over 50 academic breast cancer research groups.

India’s COVID-19 tally mounted to 1,06,90,279 with 12,689 new cases on Tuesday. As many as 1,03,59,305 people have recuperated from the infection so far pushing the national recovery rate to 96.91 per cent, according to the union health ministry’s data. As many as 13,021 recoveries and 127 fatalities were recorded during the day. The active infections stood at 1,73,731. The death toll has mounted to 1,53,751 till now. The COVID-19 case fatality rate stands at 1.44 per cent.

India saw 13,232 new COVID19 cases on Sunday. The total caseload of the state stood at 1,06,68,674 of which 1,81,480 were active infections. As many as 13,148 recoveries and 131 deaths were reported on the day. The total recoveries have reached 1,03,29,244 and the fatalities have reached 1,53,508.

India added 14,545 fresh COVID-19 cases on Friday, taking the cumulative case burden to 1,06,40,544, the health ministry’s data showed. The number of active infections stood below 2 lakhs at 1,82,831. The overall recoveries have reached 1,03,00,063, with 17,166 individuals getting cured/discharged yesterday. The nation recorded as many as 153 fatalities on the day taking the overall fatalities to 1,53,221.

India reported 14,472 new COVID-19 infections on Thursday. The total caseload has risen to 1,06,26,200 so far, with active infections at 1,85,826. The nation recorded 17,726 recoveries, and 161 deaths on the day taking the total recoveries and fatalities to 1,02,82,889 and 1,53,067 respectively.

A Texas-based firm, Seno Medical has recently received the US FDA approval for its new opto-acoustic imaging device named Imagio that could help physicians identify whether breast lesions are benign or malignant. According to the company, this non-invasive and radiation-free technology will help to reduce the number of biopsies that have to be performed.

India has reported over 15,270 new COVID-19 infections on Wednesday taking the cumulative caseload to 1,06,11,719. The active infections remained below 2 lakhs at 1,89,245. As many as 20,071 recoveries and 152 deaths due to the pandemic were recorded yesterday. The total number of recoveries have reached 1,02,65,163 while the death toll mounted to 1,52,906.

Johnson & Johnson’s subcutaneous formulation of the monoclonal antibody daratumumab and hyaluronidase-fihj (Darzalex Faspro) received the US FDA approval to treat light chain (AL) amyloidosis, a rare and often fatal blood cell disorder. The drug has been approved for use in combination with bortezomib, cyclophosphamide and dexamethasone.

India recorded 13,780 fresh cases of COVID-19 on Tuesday. The cumulative caseload has now risen to 1,05,96,442, of which 1,94,201 are active cases. As many as 17,229 recoveries were recorded on the day taking the total recoveries to 1,02,45,092 till now. With 161 recent deaths, the overall fatalities due to the pandemic in the nation have now reached 1,52,754.

India reported 9,972 new COVID-19 cases on Monday taking the cumulative case tally to 1,05,82,647. The active caseload went below 2 lakh and stood at 1,97,818, seeing 1,02,27,852 recoveries and 1,52,593 deaths so far. The nation recorded 17,116 recoveries and 137 deaths on the past day.

A phase II trial of a novel drug, dexpramipexole, showed positive top-line results in patients with moderate-to-severe eosinophilic asthma, announced Knopp Biosciences.
 

Even as India has initiated the COVID-19 vaccination, 13,962 new positive incidences were reported on Sunday. The cumulative case tally now stands at 1,05,72,672, of which 2,05,109 are active cases. The nation reported a total of 14,513 recoveries and 145 fatalities on the past day. With this, the total recoveries and death toll reported till now has elevated to 1,02,10,697 and 1,52,456 respectively.

Parexel and Signify Health have announced a strategic collaboration to bring in new solutions to promote access and inclusion of more diverse and traditionally underrepresented population in clinical trials.

The Drugs Controller General of India (DCGI) has given nod to conduct phase 3 clinical trial of Russia’s COVID-19 vaccine candidate, Sputnik V, in India, according to Dr. Reddy’s Laboratories.

India recorded 15,151 new COVID-19 infections on Friday. The cumulative confirmed cases have now risen to 1,05,43,659, of which 2,08,261 are active infections. The nation also recorded 16,801 recoveries and 176 deaths on the day taking the total recoveries and fatalities to 1,01,78,883 and 1,52,130 respectively.

The European Commission has approved baloxavir marboxil, sold under the brand name Xofluza, for the treatment of uncomplicated influenza in patients aged 12 years and above, announced Roche.

DuPont Nutrition & Biosciences has launched Howaru Calm, a probiotic aimed at helping reduce stress. The company said that Howaru Calm’s featured strain – Lactobacillus paracasei Lpc-37, was scrupulously tested to ensure its quality, efficacy and performance.

An investigational antibody donanemab, significantly slowed reduction of cognition and daily function in early Alzheimer’s disease in the phase 2 trial, according to a press release from Eli Lilly and Company.

Equilibrium in public and private health services, increased access and affordability and close looped solutions for healthcare waste are some of the most important and immediate requirements to mitigate the risks associated with COVID-19 pandemic worldwide.

India reported 15,677 new COVID-19 incidences on Thursday, pushing the cumulative case tally of the nation to 1,05,28,508. With 1,01,62,082 recoveries and 1,51,954 fatalities reported from the infection so far, the active cases have declined to 2,10,106. The nation registered 15,848 recoveries and 189 deaths in the past 24 hours. With 19 new deaths, the total fatalities have risen to 3,392.

OncoLab Diagnostics GmbH now offers tests combining PCR and immunofluorescence staining for faster and easier identification of circulating tumour cells (CTCs) for blood-based biopsy tests (BBB).

Bharat Biotech has started the supply of its COVID-19 vaccine Covaxin across India. The first batch of the indigenous vaccines has been  dispatched from Hyderabad to 11 cities.

India registered 17,015 new COVID-19 cases in the last 24 hours pushing the case tally to 1,05,12,831. As many as 17,797 cured/discharged cases were reported in the past day taking the total recoveries to 1,01,46,254. The death toll has risen to 1,51,765 with 201 new fatalities reported on Wednesday. The active cases have declined to 2,10,459, as of now. The total number of persons found to be positive with the new UK-variant COVID-19 stands at 102, said the Health Ministry.

Nephrolithiasis (kidney stone) is highly prevalent among patients with metabolic syndrome, finds a recent hospital-based study published in the Journal of the Association of Physicians of India.

India reported 12,584 new cases, lowest since June 17 on Monday, according to the union health ministry’s data. The total case tally has risen to 1,04,79,913, while the active cases continued to decline with an increasing number of recoveries. The active caseload now stood at 2,13,503. The nation recorded 18,578 discharges in the last day taking the total recoveries to 1,01,10,710. With 166 new deaths, the total fatalities have reached 1,51,364.

A phase 3 clinical trial of extended-release subcutaneous risperidone injection (TV-46000/mdc-IRM) developed by Teva Pharmaceuticals and MedinCell recently reported positive results in treating patients with schizophrenia.  Data from the study showed that patients who received the treatment had a statistically significant delay in time to relapse as compared to placebo.

India reported 16,311 new COVID-19 cases and 161 deaths in the last 24 hours, the Ministry of Health and Family Welfare (MoHFW) said on Monday. With the addition of fresh infections, the overall cases in the country reached 1,04,66,595 including 2,22,526 active cases. After 19,299 discharges in the last 24 hours, the cumulative recoveries reached 1,00,92,909. The death toll climbed to 1,51,160.

The precision oncology start-up company 4basecare has joined hands with the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) – Tata Memorial Centre for a new artificial intelligence-driven clinical interpretation platform, ClinOme.  

The UK’s regulatory authority has approved Moderna’s COVID-19 vaccine for use in the country.

With 18,453 fresh COVID -19 cases reported on Friday, India’s total case tally took to 10,432,526. The active cases now stand at 2,21,447, as the overall recoveries have surged to 1,00,55,935, with 19,242 individuals getting discharged on Friday. The death toll has mounted to 1,50,835 with 229 new deaths from the infection.

India recorded 18,094 new COVID-19 cases in the last 24 hours, pushing the case tally to 1,04,14,044, according to data from the union health ministry. The total number of recoveries reported have reached 1,00,36,722 with 20,532 among them being discharged on Thursday. The total deaths from the pandemic have reached 1,50,606 with 233 fatalities recorded yesterday. With this, the overall active cases in the country now stand at 2,22,416.

The US FDA has recently approved relugolix (Orgovyx) as the first oral androgen deprivation therapy for adults with advanced prostate cancer, announced Myovant Sciences.

India reported 20,460 new coronavirus cases on Wednesday, taking the overall case tally to 1,03,95,938, the health ministry’s data showed. The active infections stood at 2,25,120 after recording 19,662 new recoveries and 221 deaths taking the total recoveries and fatalities in the nation to 1,00,16,163 and 1,50,372 respectively. The total number of people who have tested positive for the new UK strain of the coronavirus in the country now stands at 73, according to the health ministry.

Even as the union government is considering granting emergency approval for COVID-19 vaccines, the Maharashtra chapter of the Indian Medical Association (IMA) has urged the government to test the vaccines widely before giving its approval.

The Drugs Controller General of India (DCGI) has given approval to the Oxford/AstraZeneca’s COVID-19 vaccine Covishield, manufactured by the Serum Institute of India, and to the indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.

India reported 16,678 new coronavirus infections in the past 24 hours, pushing the overall caseload to 1,03,41,291, the health ministry’s data showed.

The dry run for COVID-19 vaccination across all states has been initiated today on Jan 2 as India gears up for the roll-out of the COVID-19 vaccine in the country. The dry run is proposed to be conducted in all state capitals in at least 3 session sites.

India reported 19,078 new COVID-19 cases on Friday, taking the total number of confirmed cases in the country to 1,03,06,490, according to data from the union ministry of health and family welfare. As many as 224 lives were lost to the infection in the last 24 hours, taking the death toll to 1,49,218. The active cases stand at 2,50,183 while the total recoveries have reached 99,06,387.

The American biotech firm Novavax has initiated a phase III study of its COVID-19 vaccine candidate, NVX-CoV2373, in the US and Mexico.

The union health ministry has announced that a dry run will be conducted by all the state and union territory governments on January 2 with the objective of preparing for the roll-out of COVID-19 vaccine across India.

India recorded 21,944 fresh COVID-19 infections and 299 related deaths in the last 24 hours. With the fresh cases, the nation’s tally has surged to 1,02,67,283 of which the total active cases add up to 2,55,898, according to data from the union health ministry. As many as 98,59,762 infected individuals have been recuperated from the infection so far, with 26,406 of them getting discharged on Wednesday. The death toll due to the pandemic has soared to 1,48,774 in the nation so far.

Oxford’s COVID-19 vaccine has been approved for emergency use in the UK, announced Astra Zeneca.

India has reported 14 fresh cases of new coronavirus mutant strain, initially identified in the UK, which adds up to 20 such cases in the country so far, confirmed the health ministry on Wednesday morning

India reported 16,072 fresh COVID cases, 24,822 recoveries and 250 deaths in the last 24 hours. The overall case tally of the nation stands at 1,02,24,797, of which 2,67,017 are active cases under treatment. 

With 20,333 fresh cases reported in the last 24 hours, the total caseload of the nation added up to 1,02,08,725, according to data from the Union Health Ministry. The number of active cases declined to 2,76,028 with 97,81,945 recoveries and 1,47,940 deaths reported so far due to the pandemic. As many as 21,097 were reported as cured while 281 lost lives to the infection on Sunday.

The apex medical regulator, the National Medical Commission has recently announced relaxations on the requirement of the postgraduate thesis, in the light of the coronavirus pandemic.

The Lexington based biotech firm, Aldeyra Therapeutics has commenced phase II study of its reactive aldehyde species (RASP) inhibitor, ADX-629, for treating COVID-19, atopic asthma and psoriasis.

Eli Lilly is set to launch a new pragmatic study of its drug candidate, bamlanivimab (LY-CoV555) in high-risk patients with COVID-19 in New Mexico.

The number of daily deaths reported due to the pandemic in India fell below 300 on Friday, for the first time since June 9, and stood at 251. The total fatalities have reached 1,47,379 as of now. The overall COVID-19 incidences recorded in India has surged to 1,01,69,818 with 22,350 new infections reported in the past 24 hours. The overall active infections stood at 2,80,274 in the nation. With 22,184 patients getting discharged the total recoveries climbed to 97,39,382.

CureVac has initiated a phase III clinical trial of its COVID-19 vaccine candidate, CVnCoV, in healthcare workers at the University Medical Center Mainz, Germany. The study aims to analyse the safety and immunogenicity of CVnCoV given as a two-dose schedule of 12µg.

India recorded 23,444 new coronavirus cases on Thursday, taking the total caseload to 1,01,47,468. Less than 2.8 lakh of these are active cases, the health ministry said. A total of 1,47,092 people have died of the coronavirus in the country, with 336 of those deaths coming in the last 24 hours, the data showed.

India’s COVID-19 caseload rose to 1,01,24,024 with 24,716 new infections reported in the past 24 hours. The number of people who have recuperated from the disease surged to 96,92,643 and the active infection remained below 3 lakh at 2,81,844, according to the Union Health Ministry. The death count increased to 1,46,791 with 315 new fatalities. The national recovery rate stands at 95.69 per cent, while the COVID-19 case fatality rate stands at 1.45 per cent.

India reported 23,950 fresh cases in the past 24 hours taking the total case count to 1,00,99,308. The total recoveries have gone up to 96,63,382 with 26,895 new recoveries recorded on Wednesday. There are 2,87,432 active COVID-19 cases in the country. With 333 recent deaths reported the total fatalities have risen to 1,46,476.

The biopharma company, Boehringer Ingelheim, have initiated phase I/IIa clinical investigation of novel SARS-CoV-2 neutralising antibody, BI 767551. The study aims to provide the innovative SARS-CoV-2 neutralising antibody by combining a systemic with an inhaled route of administration.

AstraZeneca’s benralizumab (Fasenra) solution has received authorisation from the Drugs Controller General of India (DCGI) for treating severe asthma patients.

The new coronavirus strain, dubbed VUI-202012/01 (first variant under investigation in December 2020), recently spotted in the UK is said to be 70 per cent more infectious and the variant “was out of control”, said the Health Secretary Matt Hancock.

India has recorded 1,00,56,248 confirmed COVID-19 cases, after reporting 24,589 new incidences in the past 24 hours. A total of 1,45,843 deaths and 96,06,111 cases of recoveries have been registered so far from the pandemic. As many as 25,709 recoveries and 330 deaths from the infection were reported on the previous day.There are 3,02,343 active cases as of now.

Oxford’s two full-dose regimes of its COVID-19 vaccine candidate showed better immune response compared to a full-dose followed by a half-dose booster, said the university, quoting data from new phase I/II clinical trials.

The digital health tech company Watch Your Health in association with Madhavbaug, a multidisciplinary cardiac care clinic and hospital chain in India, have launched phygital healthcare platform.

The number of confirmed COVID-19 cases in India crossed the 10 million mark (1 crore) on December 18, 2020. In the last 24 hours, 26,991 fresh infections took India’s COVID tally to 1,00,04,825, as per the official data. 347 deaths linked to the infection were recorded, taking the tally to 1,45,136.

The France-based biotech company Valneva has launched the phase I/II VLA2001-201 clinical study of its COVID-19 vaccine candidate, VLA2001.

The US Food and Drug Administration (FDA) has given its nod to Moderna’s vaccine as the country’s second COVID-19 vaccine after that of Pfizer/BioNTech’s jab. The approval came on Friday, December 18, about a week after approving Pfizer’s vaccine which is now being distributed in the country.

The preliminary results from a preclinical study using a new chemical entity, opaganib, showed a reduction of thrombosis (blood clotting) in animal models with acute respiratory distress syndrome (ARDS), announced the Israel-based biopharmaceutical company, RedHill Biopharma. ARDS-induced thrombosis may happen in up to one-third of COVID-19 patients needing ICU admission and is a major cause of death.

India recorded 22,890 new coronavirus cases in the past 24 hours, taking the total caseload to over 99,79,00 lakh. Up to 338 more deaths were reported in this time, taking total fatality to 1,44,789 till now. Over 31,087 recovered since yesterday, taking the overall figure to 95,20,827. The number of fresh infections is 4.6 per cent down since Thursday.

India may have missed about 90 infections for every detected COVID-19 case until November, according to an analysis by a committee formed by the Department of Science and Technology.

Canada’s FSD Pharma has initiated its phase IIa clinical trial of FSD201 or ultramicronized palmitoylethanolamide (PEA) for treating hospitalised patients with COVID-19 .

A new digital health passport known as ‘V-Health Passport’ has been launched by the UK-based cyber technology firm VST Enterprises (VSTE) that can validate an individual’s identity, authenticate their COVID-19 test result and vaccination or immunisation details through a secure app.

The checkpoint inhibitor pembrolizumab (Keytruda, Merck) with chemotherapy showed an improved overall survival (OS) in patients with previously untreated advanced oesophageal squamous cell carcinoma (ESCC), oesophagal adenocarcinoma (EAC) or esophagogastric junction adenocarcinoma (EGJ).

Followed by the approval of the COVID-19 vaccine developed by the US. drug firm Pfizer and its German partner BioNTec, Saudi Arabia has now announced a three-phase vaccination programme and has begun registering citizens and foreign residents.

India’s active COVID-19 cases tailed off to reach 3,30,395 as on Tuesday. With the recent positively tested cases at 26,251, the overall confirmed covid incidences in the nation have risen to 99,32,908. While 383 fatalities took the death toll to 1,44,130. As many as 33,853 patients were reported as recovered yesterday taking the total recoveries to 94,55,793 in the country so far. The national recovery rate has further escalated to 95.12 per cent, according to the Union health ministry.

Doctors at Sir Ganga Ram Hospital, Delhi recently encountered multiple cases of a lethal invasive fungal infection known as mucormycosis in recovering coronavirus patients due to which nearly half of them lost their eyesight, the authorities claimed.

The biopharmaceutical company CureVac has begun a phase 2b/3 clinical trial of its mRNA-based COVID-19 vaccine candidate CVnCoV. The study plans to enroll around 36,500 participants from Europe and Latin America.

India reported 22,065 new coronavirus cases in the last 24 hours, the lowest one-day figure in since July 7, pushing the total COVID-19 caseload to reach 99,06,657.354 deaths in the last 24 hours have pushed the total death count to 1,43,709. Over 94.22 lakh people in the country have recovered since the beginning of the pandemic. The active cases under treatment stand at 3,38,403.

India reported 27,071 new COVID-19 cases in the last 24 hours. The country’s total cases reached 98,84,100 and the number of active cases declined to 3,52,586, according to the data from the Union Ministry of Health and Family Welfare (MoHFW) released on Monday morning.

Apollo Speciality Hospitals Vanagaram, has organized a mass roadshow across the Tamil Nadu to create Evoking awareness about the importance of time in the management of stroke, between 12th to 15th December.

The multi-super speciality hospital Medanta has launched a new eClinic and Nursing Unit at Uppal Southend, Sector 49, Gurugram, to promote and improve remote consultations.

Patients treated with a high dose of the human monoclonal antibody fasinumab showed improved chronic lower back pain and restored normal functioning in patients, according to data published in the Annals of the Rheumatic Diseases.

A combinational therapy including naxitamab-gqgk (Danyelza) and granulocyte-macrophage colony-stimulating factor (GM-CSF) has been approved by the US FDA for patients aged 1 year and older with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow demonstrating a response or stable disease after prior therapy.

Oxford’s COVID-19 vaccine will be combined with human adenoviral vector type Ad26 component of Russia’s Sputnik V jab in the new clinical trials to study the possibility of boosting their vaccine’s efficacy, according to a release issued by the Russian Direct Investment Fund (RDIF). The trial is set to initiate by the end of 2020.

Pfizer’s COVID-19 vaccine gets green light from USFDA for emergency use authorisation for inoculation in people aged 16 years and older. Healthcare workers and elderly people in long-term care facilities are expected to be the main recipients of the first round of 2.9 million doses, said the U.S government.

India reported 30,006 fresh COVID-19 infections, 33,494 recoveries and 442 deaths in the past 24 hours. With the new cases the total case tally of the nation has surpassed 9.8 million to reach 98,26,775 and the number of active cases dipped to 3,59,819. The number of total recoveries has reached 93,24,328, till now.

An association of leading Asian oncologists in partnership with AstraZeneca, recently conducted the New Normal, Same Cancer campaign, to empower patients to access cancer services without delay.

The COVID-19 case tally in India has risen to 97,96,770, with 29,398 new cases reported on Thursday. The death toll has risen to 1,42,186 seeing 411 new deaths. The total recovered cases have reached 92,90,834 with 37,610 patients getting cured yesterday.

Apollo Hospitals, Chennai has recently performed a corrective procedure called arthroscopic discoid meniscus saucerization and repair on a 7-year-old girl who was affected by discoid lateral meniscal tear, a rare abnormal condition in children.

India’s total confirmed cases have risen to 97,67,640 with 31,623 new infections reported in the last 24 hours. Total active cases stood at 3,70,786. As many as 37,680 new patients were recovered during the day. The death toll mounted to 1,41,810 with 412 new deaths.

Hyderabad-based vaccine and pharmaceutical firm Biological E. (BE) has recently signed a pact with the Ohio State Innovation Foundation (OSIF), USA, under which the latter will be licensing novel live attenuated recombinant measles virus vectored vaccine candidates against SARS-CoV-2 exclusively to the company.

India’s COVID-19 caseload has now reached 97,35,975 with 32,061 new incidences reported in the past 24 hours. The active cases stood at 3,77,327 as of now. As many as 36,546 patients showed recovery from the infection yesterday taking the overall recoveries to 92,14,815. With 402 recent deaths, the total fatalities due to the pandemic have risen to 1,41,398.

Interim analysis of the phase III programme conducted by Oxford University with its COVID-19 vaccine candidate AZD1222 showed that the vaccine is effective at preventing COVID-19, with no severe cases and no hospitalisations more than 21 days after the first injection.

Starting within a week to 10 days, the new FNCAS9 Editor-Limited Uniform Detection Assay or Feluda paper strip test will be incorporated for COVID-19 testing in the national capital, according to officials.

L V Prasad Eye Institute (LVPEI) and the Madurai-based Aravind Eye Care Systems will share the prestigious ‘The Greenberg Prize – End Blindness 2020’ in the ‘Outstanding Achievement Prize’ category, for their contributions to eliminate blindness.

India’s daily COVID-19 cases dipped below 27K to reach 26,207 on Monday. This was the lowest number of new cases recorded in a single day since July 8, when the count was 25,641. The total number of fatalities stood at 1,40,996 with 389 new deaths

Two out of every five people with disability (42.5%) reported that lockdown had made it difficult for them to access routine medical care, found a recent survey conducted by CBM India, a leading organisation in disability-inclusive development, in collaboration with IIPH Hyderabad and Humanity & Inclusion.

India’s COVID-19 case tally rose to 96,77,381 with 32,852 new infections in the last 24 hours. The new cases fell this week by around 16% from the previous week, reports TOI. With this, the weekly count of cases is now down by nearly two-thirds (62%) from its peak in September 6-13. The total active cases stand at 3,95,636

The health department of the southern Indian state of Kerala has decided to set up specialized clinics to ensure follow-up treatment to people who recovered from COVID-19.

Participants in HIV prevention trials feel good when helping others, found a NIAID-funded HIV Vaccine Trials Network (HVTN) cross-protocol analysis.

India’s total COVID-19 case tally rose to 95,71,559 with 36,594 new infections in last 24 hours. While the death toll mounted to 1,39,188 with 540 new deaths. Total active cases stand at 4,16,082.

AstraZeneca has launched a phase IIb clinical trial of the investigational antisense agent, ION449 (AZD8233), in patients with dyslipidemia.

India reported 35,506 fresh COVID-19 cases pushing the cumulative case tally to 95,35,234. The number of active infections stood at 4,21,604 with 40,908 people getting cured/discharged yesterday and 526 succumbing to the infection. The overall recoveries have reached 89,72,711 while the deaths have escalated to 1,38,686.

India saw 36,456 fresh COVID-19 infections on Tuesday. The cumulative case tally now stands at 94,99,710 with 4,27,524 active infections. As many as 43,203 recoveries were reported during the day taking the overall recoveries to 89,31,798. With 500 new deaths the fatalities rose to 1,38,159.